Portfolio Management Reports

Post-Patent Generic and Biosimilar Defense Strategies

Post-Patent Generic and Biosimilar Defense Strategies (PH181)

Create robust counter-generics strategies to retain products’ market share and prevent revenue erosion after patent expiration.

Pharmaceutical New Product Planning

Pharmaceutical New Product Planning (PH176)

Create a strong commercial voice to best position developing brands for future success.

Pharmaceutical Portfolio Management

Pharmaceutical Portfolio Management (PH162)

Master portfolio management and drive coordinated execution using benchmarks and best practices from pre-clinical to end of life.

Business Development and Licensing

Business Development and Licensing (PH154)

Reinforce business development and licensing capabilities to capitalize on deal opportunities, drive successful negotiations and foster lucrative pharmaceutical and biotechnology partnerships.

Pharmaceutical Lifecycle Management

Pharmaceutical Lifecycle Management (PH141)

Prolong brand life and defend market share with bold lifecycle management that supports products from pre-launch to post-patent.

Pharmaceutical Mergers and Acquisitions

Pharmaceutical Mergers and Acquisitions (PH133)

Realize deal value, target the right pharma acquisition opportunities and complete post-M&A integration as quickly as possible.

Pharmaceutical Alliance Management

Pharmaceutical Alliance Management (PH119)

Craft a robust alliance management strategy to bridge organizational gaps and drive pharma partnership project success while preparing for contingencies.

Pharmaceutical Product Relaunch

Pharmaceutical Product Relaunch (PH98)

Uncover the strategy, science, investments and timing behind common relaunch strategies.